|
ACAM2000
|
Sanofi Pasteur / Emergent BioSolutions |
2007 (United States)
|
(1)
Smallpox
|
|
Abdala
|
Center for Genetic Engineering and Biotechnology |
Unknown
|
(1)
COVID-19
|
|
Abrysvo
|
Pfizer |
2023 (United States)
|
(1)
Respiratory syncytial virus (RSV)
|
|
ActHIB
|
Sanofi Pasteur |
1992 (United Kingdom)
|
(1)
Haemophilus influenzae type b (Hib)
|
|
Adacel
|
Sanofi Pasteur |
Unknown
|
(3)
Diphtheria,
Pertussis / Whooping cough,
Tetanus
|
|
Afluria Quadrivalent
|
Seqirus |
2016 (United States)
|
(1)
Influenza
|
|
Ambirix
|
GlaxoSmithKline |
2002 (European Union)
|
(2)
Hepatitis A,
Hepatitis B
|
|
Arepanrix
|
GlaxoSmithKline Biologicals SA |
2009 (Canada)
|
(1)
Influenza
|
|
Arexvy
|
GlaxoSmithKline |
2023 (United States)
|
(1)
Respiratory syncytial virus (RSV)
|
|
Audenz
|
Seqirus, Inc. |
2020 (United States)
|
(1)
Influenza
|
|
Avaxim
|
Sanofi Pasteur |
1996 (France)
|
(1)
Hepatitis A
|
|
BARYCELA inj.
|
GC Biopharma |
2020 (Korea)
|
(1)
Chickenpox / Varicella
|
|
BCG Vaccine
|
Organon Teknika |
Unknown
|
(1)
Tuberculosis
|
|
BEVAC
|
Biological E. |
Unknown
|
(1)
Hepatitis B
|
|
BIBP / BBIBP-CorV
|
Sinopharm |
Unknown
|
(1)
COVID-19
|
|
Bexsero
|
GlaxoSmithKline |
2013 (European Union)
|
(1)
Meningococcal disease
|
|
Bimervax
|
HIPRA |
2023 (European Union)
|
(1)
COVID-19
|
|
BioThrax
|
Emergent BioDefense Corporation |
1998 (United States)
|
(1)
Anthrax
|
|
Biovac-A / Mevac-A
|
Pukang |
Unknown
|
(1)
Hepatitis A
|
|
Boostrix
|
GlaxoSmithKline |
1999 (Germany)
|
(3)
Diphtheria,
Pertussis / Whooping cough,
Tetanus
|
|
Boostrix IPV
|
GlaxoSmithKline |
2005 (United Kingdom)
|
(4)
Diphtheria,
Pertussis / Whooping cough,
Polio,
Tetanus
|
|
COVAX-19 / SpikoGen
|
Vaxine |
2021 (Iran)
|
(1)
COVID-19
|
|
COVIran Barekat
|
Shifa Pharmed Industrial / Barkat Pharmaceutical |
2021 (Iran)
|
(1)
COVID-19
|
|
Capvaxive
|
Merck Sharp & Dohme |
2024 (United States)
|
(1)
Streptococcus pneumoniae
|
|
Cecolin
|
Xiamen Innovax Biotech |
2019 (China)
|
(1)
Human papillomavirus infection (HPV)
|
|
Cervarix
|
GlaxoSmithKline |
2007 (Australia)
|
(1)
Human papillomavirus infection (HPV)
|
|
Comirnaty
|
Pfizer–BioNTech |
2020 (United Kingdom)
|
(1)
COVID-19
|
|
Convidecia
|
CanSino Biologics |
2020 (China)
|
(1)
COVID-19
|
|
Corbevax / BioE COVID-19
|
Baylor College of Medicine |
2021 (India)
|
(1)
COVID-19
|
|
CoronaVac
|
Sinovac |
2020 (China)
|
(1)
COVID-19
|
|
Covaxin
|
Bharat Biotech |
2021 (India)
|
(1)
COVID-19
|
|
CoviVac
|
Chumakov Centre |
2021 (Russia)
|
(1)
COVID-19
|
|
Covidful
|
Chinese Academy of Medical Sciences |
2021 (China)
|
(1)
COVID-19
|
|
Covishield / Vaxzevria
|
Oxford University–AstraZeneca |
2020 (United Kingdom)
|
(1)
COVID-19
|
|
Cyfendus
|
Emergent BioSolutions |
2023 (United States)
|
(1)
Anthrax
|
|
Daptacel
|
Sanofi Pasteur |
2002 (United States)
|
(3)
Diphtheria,
Pertussis / Whooping cough,
Tetanus
|
|
Dengvaxia
|
Sanofi Pasteur |
2015 (Mexico)
|
(1)
Dengue fever
|
|
Dukoral
|
Valneva |
1991 (Sweden)
|
(1)
Cholera
|
|
Easyfive-TT
|
Panacea Biotec |
Unknown
|
(5)
Diphtheria,
Haemophilus influenzae type b (Hib),
Hepatitis B,
Pertussis / Whooping cough,
Tetanus
|
|
Elovac B
|
Human Biologicals Institute–Indian Immunologicals Limited |
Unknown
|
(1)
Hepatitis B
|
|
Engerix-B
|
GlaxoSmithKline |
Unknown
|
(1)
Hepatitis B
|
|
Epaxal
|
Crucell |
Unknown
|
(1)
Hepatitis A
|
|
EpiVacCorona
|
VECTOR Center of Virology |
2020 (Russia)
|
(1)
COVID-19
|
|
Ervebo
|
Merck Sharp & Dohme Corp |
2019 (European Union)
|
(1)
Ebola
|
|
Eupenta
|
LG Chem |
Unknown
|
(5)
Diphtheria,
Haemophilus influenzae type b (Hib),
Hepatitis B,
Pertussis / Whooping cough,
Tetanus
|
|
Eupolio Inj.
|
LG Chem |
Unknown
|
(1)
Polio
|
|
Euvichol-Plus
|
EuBiologics |
Unknown
|
(1)
Cholera
|
|
Euvichol-S
|
EuBiologics |
2023 (Korea)
|
(1)
Cholera
|
|
FAKHRAVAC
|
Organization of Defensive Innovation and Research |
Unknown
|
(1)
COVID-19
|
|
FLU-M
|
Saint Petersburg Scientific Research Institute of Vaccines and Serums |
Unknown
|
(1)
Influenza
|
|
Fendrix
|
GlaxoSmithKline |
2005 (European Union)
|
(2)
Hepatitis A,
Hepatitis B
|
|
FluQuadri
|
Sanofi Pasteur |
Unknown
|
(1)
Influenza
|
|
Fluad Quadrivalent
|
Seqirus |
2020 (United States)
|
(1)
Influenza
|
|
Fluarix QIV
|
GlaxoSmithKline |
2012 (United States)
|
(1)
Influenza
|
|
Flublok Quadrivalent
|
Sanofi Pasteur |
2016 (United States)
|
(1)
Influenza
|
|
Flucelvax Quadrivalent
|
Seqirus |
2016 (United States)
|
(1)
Influenza
|
|
Flulaval QIV
|
GlaxoSmithKline |
2013 (United States)
|
(1)
Influenza
|
|
Fluzone High Dose Quadrivalent
|
Sanofi Pasteur |
2019 (United States)
|
(1)
Influenza
|
|
Fluzone Quadrivalent
|
Sanofi Pasteur |
2013 (United States)
|
(1)
Influenza
|
|
Gardasil
|
Merck Sharp & Dohme LLC |
2006 (United States)
|
(1)
Human papillomavirus infection (HPV)
|
|
Gardasil 9
|
Merck |
2014 (United States)
|
(1)
Human papillomavirus infection (HPV)
|
|
Genevac B
|
Serum Institute of India |
Unknown
|
(1)
Hepatitis B
|
|
HEV 239
|
Xiamen Innovax Biotech |
Unknown
|
(1)
Hepatitis E
|
|
HEXASIIL
|
Serum Institute of India |
Unknown
|
(6)
Diphtheria,
Haemophilus influenzae type b (Hib),
Hepatitis B,
Pertussis / Whooping cough,
Polio,
Tetanus
|
|
Havrix
|
GlaxoSmithKline |
Unknown
|
(1)
Hepatitis A
|
|
Healive
|
Sinovac |
Unknown
|
(1)
Hepatitis A
|
|
Heplisav-B
|
Dynavax Technologies Corporation |
2017 (United States)
|
(1)
Hepatitis B
|
|
Hexaxim
|
Sanofi Pasteur |
2013 (European Union)
|
(6)
Diphtheria,
Haemophilus influenzae type b (Hib),
Hepatitis B,
Pertussis / Whooping cough,
Polio,
Tetanus
|
|
Hiberix
|
GlaxoSmithKline |
Unknown
|
(1)
Haemophilus influenzae type b (Hib)
|
|
IMOVAX
|
Sanofi Pasteur |
1975 (Cameroon)
|
(1)
Rabies
|
|
IPOL
|
Sanofi Pasteur |
1990 (United States)
|
(1)
Polio
|
|
Imogam Rabies – HT
|
Sanofi Pasteur |
Unknown
|
(1)
Rabies
|
|
Imojev
|
Sanofi Pasteur |
Unknown
|
(1)
Japanese encephalitis
|
|
Imovax Polio
|
Sanofi Pasteur |
Unknown
|
(1)
Polio
|
|
Infanrix
|
GlaxoSmithKline |
1994 (Germany)
|
(3)
Diphtheria,
Pertussis / Whooping cough,
Tetanus
|
|
Infanrix IPV
|
GlaxoSmithKline |
Unknown
|
(4)
Diphtheria,
Pertussis / Whooping cough,
Polio,
Tetanus
|
|
Ixchiq
|
Valneva |
2023 (United States)
|
(1)
Chikungunya
|
|
Ixiaro
|
Valneva |
2009 (United States)
|
(1)
Japanese encephalitis
|
|
JEEV
|
Biological E. |
2011 (India)
|
(1)
Japanese encephalitis
|
|
Janssen / Johnson & Johnson COVID-19 vaccine
|
Janssen / Johnson & Johnson |
2021 (Bahrain)
|
(1)
COVID-19
|
|
KCONVAC
|
Beijing Minhai Biotechnology / Shenzhen Kangtai |
2021 (China)
|
(1)
COVID-19
|
|
Kinrix
|
GlaxoSmithKline |
2008 (United States)
|
(4)
Diphtheria,
Pertussis / Whooping cough,
Polio,
Tetanus
|
|
Kostaive
|
Seqirus Netherlands B.V. |
2023 (Japan)
|
(1)
COVID-19
|
|
LC16 KMB / LC16m8
|
KM Biologics |
Unknown
|
(1)
Smallpox
|
|
M-M-R II
|
Merck Vaccines |
1978 (United States)
|
(3)
Measles,
Mumps,
Rubella
|
|
MVA-BN / Imvanex / Imvamune / Jynneos
|
Bavarian Nordic |
2013 (European Union)
|
(1)
Smallpox
|
|
MVC-COV1901
|
Medigen Vaccine Biologics / Dynavax Technologies / NIH |
2021 (Taiwan)
|
(1)
COVID-19
|
|
MenAfriVac
|
Serum Institute of India |
Unknown
|
(1)
Meningococcal disease
|
|
MenFive
|
Serum Institute of India |
Unknown
|
(1)
Meningococcal disease
|
|
MenQuadfi
|
Sanofi Pasteur |
2020 (United States)
|
(1)
Meningococcal disease
|
|
Menactra
|
Sanofi Pasteur |
2005 (United States)
|
(1)
Meningococcal disease
|
|
Menitorix
|
GlaxoSmithKline |
2005 (United Kingdom)
|
(2)
Haemophilus influenzae type b (Hib),
Meningococcal disease
|
|
Menjugate
|
GlaxoSmithKline |
Unknown
|
(1)
Meningococcal disease
|
|
Menveo
|
GlaxoSmithKline |
2010 (United States)
|
(1)
Meningococcal disease
|
|
Mosquirix
|
GlaxoSmithKline |
Unknown
|
(1)
Malaria
|
|
Mvabea
|
Janssen / Johnson & Johnson |
2020 (European Union)
|
(1)
Ebola
|
|
Nimenrix
|
Pfizer |
2012 (European Union)
|
(1)
Meningococcal disease
|
|
Nuvaxovid / Covovax
|
Novavax |
2021 (Indonesia)
|
(1)
COVID-19
|
|
PNEUBEVAX 14
|
Biological E. |
Unknown
|
(1)
Streptococcus pneumoniae
|
|
Pediarix
|
GlaxoSmithKline |
2002 (United States)
|
(5)
Diphtheria,
Hepatitis B,
Pertussis / Whooping cough,
Polio,
Tetanus
|
|
PedvaxHIB
|
Merck Sharp & Dohme Corp. |
1989 (United States)
|
(1)
Haemophilus influenzae type b (Hib)
|
|
Penbraya
|
Pfizer |
2023 (United States)
|
(1)
Meningococcal disease
|
|
Penmenvy
|
GlaxoSmithKline |
2025 (United States)
|
(1)
Meningococcal disease
|
|
Pentacel
|
Sanofi Pasteur |
1997 (Canada)
|
(5)
Diphtheria,
Haemophilus influenzae type b (Hib),
Pertussis / Whooping cough,
Polio,
Tetanus
|
|
Pentaxim
|
Sanofi Pasteur |
Unknown
|
(5)
Diphtheria,
Haemophilus influenzae type b (Hib),
Pertussis / Whooping cough,
Polio,
Tetanus
|
|
Pneumosil
|
Serum Institute of India |
Unknown
|
(1)
Streptococcus pneumoniae
|
|
Pneumovax 23
|
Merck Sharp & Dohme Corp |
1983 (United States)
|
(1)
Streptococcus pneumoniae
|
|
PreHevbrio
|
VBI Vaccines Inc. |
Unknown
|
(1)
Hepatitis B
|
|
Prevnar 13
|
Pfizer |
2009 (European Union)
|
(1)
Streptococcus pneumoniae
|
|
Prevnar 20
|
Pfizer |
2021 (United States)
|
(1)
Streptococcus pneumoniae
|
|
Priorix
|
GlaxoSmithKline |
1997 (United Kingdom)
|
(3)
Measles,
Mumps,
Rubella
|
|
Priorix-Tetra
|
GlaxoSmithKline |
2007 (United Kingdom)
|
(4)
Chickenpox / Varicella,
Measles,
Mumps,
Rubella
|
|
ProQuad
|
Merck Vaccines |
2005 (United States)
|
(4)
Chickenpox / Varicella,
Measles,
Mumps,
Rubella
|
|
QIV
|
Sanofi Pasteur |
Unknown
|
(1)
Influenza
|
|
QazCovid-in / QazVac
|
Research Institute for Biological Safety Problems |
2020 (Kazakhstan)
|
(1)
COVID-19
|
|
Qdenga
|
Takeda |
2022 (Indonesia)
|
(1)
Dengue fever
|
|
Quadracel
|
Sanofi Pasteur |
1997 (Canada)
|
(4)
Diphtheria,
Pertussis / Whooping cough,
Polio,
Tetanus
|
|
R21/Matrix-M / CYVAC
|
Serum Institute of India / University of Oxford |
2023 (Ghana)
|
(1)
Malaria
|
|
REPEVAX
|
Sanofi Pasteur |
2001 (United Kingdom)
|
(4)
Diphtheria,
Pertussis / Whooping cough,
Polio,
Tetanus
|
|
RabAvert
|
GlaxoSmithKline / Bavarian Nordic |
1997 (United States)
|
(1)
Rabies
|
|
Rabipur
|
Valneva |
1984 (Germany)
|
(1)
Rabies
|
|
Rabivax-S
|
Serum Institute of India |
Unknown
|
(1)
Rabies
|
|
Razi Cov Pars
|
Razi Vaccine and Serum Research Institute |
Unknown
|
(1)
COVID-19
|
|
Recombivax HB
|
Merck |
1986 (United States)
|
(1)
Hepatitis B
|
|
Revaxis
|
Sanofi Pasteur |
2003 (United Kingdom)
|
(3)
Diphtheria,
Polio,
Tetanus
|
|
RotaTeq
|
Merck Sharp & Dohme Corp |
2006 (United States)
|
(1)
Rotavirus
|
|
Rotarix
|
GlaxoSmithKline |
2004 (Mexico)
|
(1)
Rotavirus
|
|
Rotasiil
|
Serum Institute of India |
Unknown
|
(1)
Rotavirus
|
|
Rotavac
|
Bharat Biotech |
Unknown
|
(1)
Rotavirus
|
|
SKYTyphoid Multi Inj.
|
SK Bioscience |
Unknown
|
(1)
Typhoid
|
|
SKYVaricella Inj.
|
SK Bioscience |
Unknown
|
(1)
Chickenpox / Varicella
|
|
Shan5
|
Sanofi Pasteur |
Unknown
|
(5)
Diphtheria,
Haemophilus influenzae type b (Hib),
Hepatitis B,
Pertussis / Whooping cough,
Tetanus
|
|
ShanIPV
|
Sanofi Pasteur |
Unknown
|
(1)
Polio
|
|
ShanTT
|
Sanofi Pasteur |
Unknown
|
(1)
Tetanus
|
|
Shanchol
|
Sanofi Pasteur |
Unknown
|
(1)
Cholera
|
|
Shanvac B
|
Shantha Biotechnics / Sanofi |
Unknown
|
(1)
Hepatitis B
|
|
Shingrix
|
GlaxoSmithKline |
2017 (United States)
|
(1)
Shingles / Zoster
|
|
Sinopharm CNBG COVID-19 vaccine
|
China National Biotec Group (CNBG) / Sinopharm |
Unknown
|
(1)
COVID-19
|
|
Soberana 02 / Pasteurcovac
|
Finlay Institute / Pasteur Institute of Iran |
Unknown
|
(1)
COVID-19
|
|
Spikevax
|
Moderna |
2020 (United States)
|
(1)
COVID-19
|
|
Sputnik V / Gam-COVID-Vac
|
Gamaleya Research Institute of Epidemiology and Microbiology |
2020 (Russia)
|
(1)
COVID-19
|
|
Stamaril
|
Sanofi Pasteur |
Unknown
|
(1)
Yellow fever
|
|
Supemtek
|
Sanofi Pasteur |
Unknown
|
(1)
Influenza
|
|
Synflorix
|
GlaxoSmithKline |
2009 (European Union)
|
(1)
Streptococcus pneumoniae
|
|
TDVAX
|
MassBiologics |
1967 (United States)
|
(2)
Diphtheria,
Tetanus
|
|
TENIVAC
|
Sanofi Pasteur |
2003 (United States)
|
(2)
Diphtheria,
Tetanus
|
|
TICOVAC
|
Pfizer |
1976 (Austria)
|
(1)
Tick-borne encephalitis
|
|
TRUMENBA
|
Pfizer |
2014 (United States)
|
(1)
Meningococcal disease
|
|
TYPHIBEV
|
Biological E. |
2020 (India)
|
(1)
Typhoid
|
|
Tetraxim
|
Sanofi Pasteur |
Unknown
|
(4)
Diphtheria,
Pertussis / Whooping cough,
Polio,
Tetanus
|
|
Tresivac
|
Serum Institute of India |
Unknown
|
(3)
Measles,
Mumps,
Rubella
|
|
Turkovac / ERUCOV-VAC
|
Health Institutes of Turkey / Erciyes University |
2021 (Türkiye)
|
(1)
COVID-19
|
|
Twinrix
|
GlaxoSmithKline |
Unknown
|
(2)
Hepatitis A,
Hepatitis B
|
|
Typbar-TCV
|
Bharat Biotech International |
2012 (India)
|
(1)
Typhoid
|
|
Typhim Vi
|
Sanofi Pasteur |
1988 (France)
|
(1)
Typhoid
|
|
VAXNEUVANCE
|
Merck Sharp & Dohme Corp |
2021 (United States)
|
(1)
Streptococcus pneumoniae
|
|
VLA2001 / VLA2101
|
Valneva |
2022 (Bahrain)
|
(1)
COVID-19
|
|
Vaqta
|
Merck |
1996 (United States)
|
(1)
Hepatitis A
|
|
Varilrix
|
GlaxoSmithKline |
1984 (Germany)
|
(1)
Chickenpox / Varicella
|
|
Varivax
|
Merck Vaccines |
1995 (United States)
|
(1)
Chickenpox / Varicella
|
|
Vaxchora
|
Emergent BioSolutions |
2016 (United States)
|
(1)
Cholera
|
|
Vaxelis
|
MSP Vaccine Company / Sanofi Pasteur |
2016 (European Union)
|
(6)
Diphtheria,
Haemophilus influenzae type b (Hib),
Hepatitis B,
Pertussis / Whooping cough,
Polio,
Tetanus
|
|
Vaxigrip
|
Sanofi Pasteur |
Unknown
|
(1)
Influenza
|
|
ViATIM
|
Sanofi Pasteur |
Unknown
|
(2)
Hepatitis A,
Typhoid
|
|
Vidprevtyn
|
Sanofi Pasteur / GlaxoSmithKline |
2022 (European Union)
|
(1)
COVID-19
|
|
Vimkunya
|
Bavarian Nordic |
2025 (United States)
|
(1)
Chikungunya
|
|
Vivotif
|
Emergent BioSolutions / Crucell Switzerland AG |
1983 (Europe)
|
(1)
Typhoid
|
|
WIBP-CorV
|
Sinopharm |
2021 (China)
|
(1)
COVID-19
|
|
Walrinvax
|
Yuxi Zerun Biotechnology |
2022 (China)
|
(1)
Human papillomavirus infection (HPV)
|
|
YF-Vax
|
Sanofi Pasteur |
Unknown
|
(1)
Yellow fever
|
|
Zabdeno
|
Janssen / Johnson & Johnson |
2020 (European Union)
|
(1)
Ebola
|
|
Zifivax / ZF2001
|
Anhui Zhifei Longcom / Institute of Microbiology at the Chinese Academy of S |
Unknown
|
(1)
COVID-19
|
|
Zostavax
|
Merck |
2006 (United States)
|
(1)
Shingles / Zoster
|
|
ZyCoV-D
|
Cadila Healthcare |
2021 (India)
|
(1)
COVID-19
|
|
ZyVac TCV
|
Zydus Lifesciences |
Unknown
|
(1)
Typhoid
|
|
mCombriax
|
Moderna Biotech Spain, S.L. |
2026 (European Union)
|
(2)
COVID-19,
Influenza
|
|
mNEXSPIKE
|
Moderna |
2025 (United States)
|
(1)
COVID-19
|
|
mRESVIA
|
Moderna |
2024 (United States)
|
(1)
Respiratory syncytial virus (RSV)
|